University of Amsterdam — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsalert

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Optimizing First-line therapy for aggressive neuroblastoma by systems medicine strategies overcoming secindary drug resitance

Home
Explore Partnerships
Partnerships
ERACoSysMed
1st Call: European Research Projects to demonstrate the feasibility and benefits of systems medicine
Optimizing First-line therapy for aggressive neuroblastoma by systems medicine strategies overcoming secindary drug resitance
University of Amsterdam

Full name	University of Amsterdam
Short name	UvA
Type of organisation	Academia
Partner Role	Partner
Country	Netherlands

Back to project overview

Funded by the European Union under the Grant Agreement no. 101102316. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on LinkedIn

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.